Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.
In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.
The deal is worth roughly $2.8 billion.
In general, physicians believe that information provided by pharma companies is difficult to find and lacking in science.
This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.
Bayer, Eli Lilly, GlaxoSmithKline, and Sanofi have suspended advertising on the show, according to news reports.
WPP creates WPP Health & Wellness; Publicis Health formalizes new name; 10 ways healthcare companies are testing Instagram
Drugmakers are becoming much more cautious with their budgets, WebMD executives said.
The company acquired Everyday Health in December.
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
A recent CME course using Facebook Live generated 34,000 views and 600 comments.
How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy
Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.
The partnership allows Sermo to expand the reach of its research initiatives and Everyday Health to scale its targeted advertising on the social platform.
Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines